Gene · 57126
Papers3,864
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,864
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Corrigendum to: 'CD177+ cells produce neutrophil extracellular traps that promote biliary atresia' (J Hepatol [2022] 77:1299-1310). | J Hepatol | 2025 | 40764185 | PubTator, text mining | PubMed |
| Temporal phenotyping of neutrophils in post-cardiac arrest syndrome and extracorporeal membrane oxygenation-assisted resuscitation: A pilot study. | PLoS One | 2025 | 40743049 | PubTator, text mining | PubMed |
| Programmable protein ligation on cell surfaces. | Nature | 2025 | 40739351 | PubTator, text mining | PubMed |
| Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study. | J Inflamm Res | 2025 | 40626035 | PubTator, text mining | PubMed |
| Surface keratin 1, a tumor-selective peptide target in human triple-negative breast cancer. | Sci Rep | 2025 | 40595898 | PubTator, text mining | PubMed |
| Highly sensitive nanobody-immunosensor for macrophage-capping protein. | Biosens Bioelectron | 2025 | 40518371 | PubTator, text mining | PubMed |
| Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and Metastasis. | bioRxiv | 2025 | 40501715 | PubTator, text mining | PubMed |
| Exploring the causal links between inflammation-related genes and atherosclerosis through Mendelian randomization analysis. | Medicine (Baltimore) | 2025 | 40489880 | PubTator, text mining | PubMed |
| Targeting mitochondrial complex I of CD177+ neutrophils alleviates lung ischemia-reperfusion injury. | Cell Rep Med | 2025 | 40398393 | PubTator, text mining | PubMed |
| Synthetic Biology-Based Engineering Cells for Drug Delivery. | Exploration (Beijing) | 2025 | 40395752 | PubTator, text mining | PubMed |
| Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells. | Immunity | 2025 | 40381622 | PubTator, text mining | PubMed |
| Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases. | MAbs | 2025 | 40367237 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Key Pathways Associated with Sepsis Progression Using Weighted Gene Co-Expression Network Analysis and Machine Learning. | Int J Mol Sci | 2025 | 40362669 | PubTator, text mining | PubMed |
| St3gal5-mediated sialylation of glyco-CD177 on neutrophils restricts neuroinflammation following CNS injury. | Proc Natl Acad Sci U S A | 2025 | 40244680 | PubTator, text mining | PubMed |
| Uncovering critical transitions and molecule mechanisms in disease progressions using Gaussian graphical optimal transport. | Commun Biol | 2025 | 40189710 | PubTator, text mining | PubMed |
| Fluorescence Probes Based on Aminoboranes for the Detection of Fluoride Ions and Nitroaromatics: A Bifunctional Fluorescence Detection Platform. | Luminescence | 2025 | 40170589 | PubTator, text mining | PubMed |
| Regulatory role of CD177+ neutrophils in BMP signaling pathway and its implications for inflammatory bowel disease, sepsis, and intestinal tumors. | Transl Oncol | 2025 | 40158420 | PubTator, text mining | PubMed |
| Integrating bioinformatics and machine learning for comprehensive analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in pediatric septic shock. | Sci Rep | 2025 | 40140612 | PubTator, text mining | PubMed |
| Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing. | Vox Sang | 2025 | 40132664 | PubTator, text mining | PubMed |
| SMARCC1 promotes M2 macrophage polarization and reduces ferroptosis in lung cancer by activating FLOT1 transcription. | J Mol Med (Berl) | 2025 | 40108025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57126/papers?page=5